Latest Revenue Forecast News

Vista Group International posted a 12% revenue increase in 1H26, driven by cloud adoption and marquee client wins, prompting an upgrade to its full-year revenue forecast.

Synertec has locked in a $4 million contract to upgrade AGL’s national SCADA system, reinforcing its foothold in critical infrastructure technology as it forecasts up to 50% revenue growth in FY27.

Proteomics International Laboratories has streamlined operations, secured a key US patent for its endometriosis test, and inked a three-year exclusive distribution deal with Healius for its Promarker diagnostics in Australia.

Axtec has secured a strategic partnership with MRI Software to integrate its full product suite into widely used Australian real estate software, opening a major distribution channel across agent networks nationwide.

Vinyl Group has expanded its media footprint through key acquisitions, boosting national audience reach and setting a clear path to profitability in FY27 with AI-driven Adaptive Media strategies.

IDT Australia boosts its FY26 revenue guidance to $16.8 million, anticipating a substantial narrowing of EBITDA losses to under $1 million, driven by strong demand and cost efficiencies.

AFT Pharmaceuticals has received tentative US FDA approval for its Scomara cream to treat Facial Angiofibromas in Tuberous Sclerosis, but US commercialisation is postponed until 2029 due to orphan drug exclusivity. The approval bolsters regulatory prospects in other key markets where AFT anticipates competitive advantages.

AFT Pharmaceuticals secures tentative FDA approval for Scomara cream to treat rare facial tumours but faces a US launch delay due to orphan drug exclusivity. The approval bolsters prospects in other markets where AFT expects competitive advantages.

Telix Pharmaceuticals reported a 21% year-on-year revenue jump to US$247 million in Q2 2026, buoyed by strong Precision Medicine sales and a new Regeneron partnership. The company also secured FDA alignment on a pivotal prostate cancer trial and expanded its manufacturing footprint.

Weebit Nano has lifted its FY 2026 revenue forecast by over 12%, citing growth in customer projects ahead of its full-year results.

Advance ZincTek expects a 13% increase in unaudited profit before tax for FY26, driven by a 12.65% rise in sales revenue amid growing global enquiries.

Ava Risk Group expects FY2026 revenue around $29 million, below prior guidance, due to delayed orders mainly in the Middle East and North America. Despite this, sales intake exceeded revenue, underpinning a strong backlog and positive EBITDA.